Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease

被引:74
作者
Lin, Ming-Tai [1 ,2 ]
Chang, Chin-Hao [3 ]
Sun, Li-Chuan [4 ]
Liu, Hsin-Min [1 ,2 ]
Chang, Huei-Wen [5 ]
Chen, Chun-An [1 ,2 ]
Chiu, Shuenn-Nan [1 ,2 ]
Lu, Chun-Wei [1 ,2 ]
Chang, Luan-Yin [1 ,2 ]
Wang, Jou-Kou [1 ,2 ]
Wu, Mei-Hwan [1 ,2 ]
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10764, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan
[4] Cardinal Tien Hosp, Dept Pediat, Taipei, Taiwan
[5] Natl Translat Med & Clin Trial Resource Ctr, Taipei, Taiwan
关键词
Kawasaki disease; immunoglobulin; score; lymphadenopathy; albumin; GAMMA-GLOBULIN THERAPY; PREDICTION; NONRESPONSIVENESS; PREDNISOLONE; RESISTANCE; EFFICACY; FAILURE;
D O I
10.1016/j.jfma.2015.03.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/purpose: Kawasaki disease (KD) is the most common pediatric vasculitis. The study aimed to identify the risk factors of intravenous immunoglobulin (IVIG) unresponsiveness from the initial clinical parameters of the Taiwanese KD patients. Methods: We enrolled 248 KD (development dataset: 181, validation: 67) patients who received IVIG within 10 days after fever onset. IVIG unresponsiveness was defined by persistent fever beyond 24 hours after IVIG or recrudescent fever with KD symptoms. Results: From the development dataset (181 patients), IVIG unresponsiveness was noted in 22 patients (12.1%). The preIVIG levels of albumin, percentage of neutrophils, and positive lymphadenopathy were identified with highest risk for IVIG unresponsiveness. These three variables were used to construct a three-variable logistic regression model, which yielded an area under the receiver-operating-characteristics curve of 0.87. These three variables were further used to generate a composite scoring model (Formosa score) which yielded a sensitivity of 90.9% and specificity of 81.3% for a cut-off point of three or more. Validation in an independent cohort (67 KD patients) yielded sensitivity and specificity of 71.4% and 81.0%, respectively. Conclusion: We have established a simple three-variable Formosa score for KD patients to identify early those at risk of IVIG unresponsiveness for timely aggressive immunomodulation initially. Copyright (C) 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 23 条
  • [1] PATHOLOGY OF KAWASAKI DISEASE .2. DISTRIBUTION AND INCIDENCE OF THE VASCULAR-LESIONS
    AMANO, S
    HAZAMA, F
    HAMASHIMA, Y
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1979, 43 (08): : 741 - 748
  • [2] Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)
    Ayusawa, M
    Sonobe, T
    Uemura, S
    Ogawa, S
    Nakamura, Y
    Kiyosawa, N
    Ishii, M
    Harada, K
    [J]. PEDIATRICS INTERNATIONAL, 2005, 47 (02) : 232 - 234
  • [3] INTRAHEPATIC BILE-DUCT DAMAGE IN CHILDREN WITH KAWASAKI-DISEASE
    BADERMEUNIER, B
    HADCHOUEL, M
    FABRE, M
    ARNOUD, MD
    DOMMERGUES, JP
    [J]. JOURNAL OF PEDIATRICS, 1992, 120 (05) : 750 - 752
  • [4] Burns JC, 2006, PEDIATR INFECT DIS J, V17, P1144
  • [5] Immunoglobulin failure and retreatment in Kawasaki disease
    Durongpisitkul, K
    Soongswang, J
    Laohaprasitiporn, D
    Nana, A
    Prachuabmoh, C
    Kangkagate, C
    [J]. PEDIATRIC CARDIOLOGY, 2003, 24 (02) : 145 - 148
  • [6] Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
    Egami, Kimiyasu
    Muta, Hiromi
    Ishii, Masahiro
    Suda, Kenji
    Sugahara, Yoko
    Iemura, Motofumi
    Matsuishi, Toyojiro
    [J]. JOURNAL OF PEDIATRICS, 2006, 149 (02) : 237 - 240
  • [7] Abnormal Liver Panel in Acute Kawasaki Disease
    ElAdawy, Mohammed
    Dominguez, Samuel R.
    Anderson, Marsha S.
    Glode, Mary P.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (02) : 141 - 144
  • [8] Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset
    Fukunishi, M
    Kikkawa, M
    Hamana, K
    Onodera, T
    Matsuzaki, K
    Matsumoto, Y
    Hara, J
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (02) : 172 - 176
  • [9] Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease
    Kobayashi, Tohru
    Kobayashi, Tomio
    Morikawa, Akihiro
    Ikeda, Kentaro
    Seki, Mitsuru
    Shimoyama, Shinya
    Ishii, Yoichiro
    Suzuki, Takahiro
    Nakajima, Kimiko
    Sakamoto, Naoko
    Arakawa, Hirokazu
    [J]. JOURNAL OF PEDIATRICS, 2013, 163 (02) : 521 - +
  • [10] Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
    Kobayashi, Tohru
    Saji, Tsutomu
    Otani, Tetsuya
    Takeuchi, Kazuo
    Nakamura, Tetsuya
    Arakawa, Hirokazu
    Kato, Taichi
    Hara, Toshiro
    Hamaoka, Kenji
    Ogawa, Shunichi
    Miura, Masaru
    Nomura, Yuichi
    Fuse, Shigeto
    Ichida, Fukiko
    Seki, Mitsuru
    Fukazawa, Ryuji
    Ogawa, Chitose
    Furuno, Kenji
    Tokunaga, Hirohide
    Takatsuki, Shinichi
    Hara, Shinya
    Morikawa, Akihiro
    [J]. LANCET, 2012, 379 (9826) : 1613 - 1620